Winn RA - Search Results

1

Antitumorigenic effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is mediated through ERK-5-dependent activation of peroxisome proliferator-activated receptor gamma.

Winn RA, Van Scoyk M, Hammond M, Rodriguez K, Crossno JT Jr, Heasley LE, Nemenoff RA. Winn RA, et al. J Biol Chem. 2006 Sep 15;281(37):26943-50. doi: 10.1074/jbc.M604145200. Epub 2006 Jul 11. J Biol Chem. 2006. PMID: 16835228 Free article.

2

gamma-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth.

Winn RA, Bremnes RM, Bemis L, Franklin WA, Miller YE, Cool C, Heasley LE. Winn RA, et al. Oncogene. 2002 Oct 24;21(49):7497-506. doi: 10.1038/sj.onc.1205963. Oncogene. 2002. PMID: 12386812

3

Peroxisome proliferator-activated receptor-gamma is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth.

Wick M, Hurteau G, Dessev C, Chan D, Geraci MW, Winn RA, Heasley LE, Nemenoff RA. Wick M, et al. Among authors: winn ra. Mol Pharmacol. 2002 Nov;62(5):1207-14. doi: 10.1124/mol.62.5.1207. Mol Pharmacol. 2002. PMID: 12391285

4

Gamma-catenin expression is reduced or absent in a subset of human non-small cell lung cancers, and its re-expression inhibits cell growth.

Winn RA, Heasley LE. Winn RA, et al. Chest. 2004 May;125(5 Suppl):122S-3S. doi: 10.1378/chest.125.5_suppl.122s. Chest. 2004. PMID: 15136458 No abstract available.

5

Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC).

Bren-Mattison Y, Van Putten V, Chan D, Winn R, Geraci MW, Nemenoff RA. Bren-Mattison Y, et al. Among authors: winn r. Oncogene. 2005 Feb 17;24(8):1412-22. doi: 10.1038/sj.onc.1208333. Oncogene. 2005. PMID: 15608671

6

Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation.

Winn RA, Marek L, Han SY, Rodriguez K, Rodriguez N, Hammond M, Van Scoyk M, Acosta H, Mirus J, Barry N, Bren-Mattison Y, Van Raay TJ, Nemenoff RA, Heasley LE. Winn RA, et al. J Biol Chem. 2005 May 20;280(20):19625-34. doi: 10.1074/jbc.M409392200. Epub 2005 Feb 10. J Biol Chem. 2005. PMID: 15705594 Free article.

7

Role of nuclear receptors in lung tumourigenesis.

Nemenoff RA, Winn RA. Nemenoff RA, et al. Among authors: winn ra. Eur J Cancer. 2005 Nov;41(16):2561-8. doi: 10.1016/j.ejca.2005.08.015. Epub 2005 Sep 30. Eur J Cancer. 2005. PMID: 16199155 Review.

8

Inhibited neurogenesis in JNK1-deficient embryonic stem cells.

Amura CR, Marek L, Winn RA, Heasley LE. Amura CR, et al. Among authors: winn ra. Mol Cell Biol. 2005 Dec;25(24):10791-802. doi: 10.1128/MCB.25.24.10791-10802.2005. Mol Cell Biol. 2005. PMID: 16314504 Free PMC article.

9

Role of the wnt signaling pathway and lung cancer.

Tennis M, Van Scoyk M, Winn RA. Tennis M, et al. Among authors: winn ra. J Thorac Oncol. 2007 Oct;2(10):889-92. doi: 10.1097/JTO.0b013e318153fdb1. J Thorac Oncol. 2007. PMID: 17909349 Free article. Review. No abstract available.

10

Antitumorigenic effects of peroxisome proliferator-activated receptor-gamma in non-small-cell lung cancer cells are mediated by suppression of cyclooxygenase-2 via inhibition of nuclear factor-kappaB.

Bren-Mattison Y, Meyer AM, Van Putten V, Li H, Kuhn K, Stearman R, Weiser-Evans M, Winn RA, Heasley LE, Nemenoff RA. Bren-Mattison Y, et al. Among authors: winn ra. Mol Pharmacol. 2008 Mar;73(3):709-17. doi: 10.1124/mol.107.042002. Epub 2007 Nov 30. Mol Pharmacol. 2008. PMID: 18055759

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters